Systematic meta-analysis of the toxicities and side effects of the targeted drug lenvatinib.

ABSTRACT:

Background

Lenvatinib, an effective targeted drug for various cancers, has clinical medication safety concerns due to its toxicities and side effects.

Objective

This study evaluated lenvatinib-induced any adverse events (any AEs) and nine aspects: vascular toxicities related to the circulatory system (vascular toxicities, blood system, and heart), toxicities of the skin and its appendages (skin/subcutaneous tissue and taste system), toxicities of the respiratory system (respiratory, thoracic, and mediastinal and respiratory tract), toxicities of the nervous system (nervous system and general), toxicities of the digestive system (gastrointestinal and liver), toxicities of the urinary system, toxicities of the endocrine and metabolic system (endocrine and metabolism/nutrition)

SUBMITTER: Liu H 

PROVIDER: S-EPMC12777875 | biostudies-literature | 2026 Dec

REPOSITORIES: biostudies-literature